Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (Fv-IgG)  (BSDG-H298)

Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD55 IgG with similar domains from an anti-HLA-A antibody via short peptide linkers, or vice versa. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.

Datasheet